NO981719L - Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b - Google Patents
Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100bInfo
- Publication number
- NO981719L NO981719L NO981719A NO981719A NO981719L NO 981719 L NO981719 L NO 981719L NO 981719 A NO981719 A NO 981719A NO 981719 A NO981719 A NO 981719A NO 981719 L NO981719 L NO 981719L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- medications
- containing protein
- medicines
- survival
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 102100021487 Protein S100-B Human genes 0.000 title abstract 3
- 101710122255 Protein S100-B Proteins 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 238000002483 medication Methods 0.000 title 2
- 102000011425 S100 Calcium Binding Protein beta Subunit Human genes 0.000 abstract 1
- 108010023918 S100 Calcium Binding Protein beta Subunit Proteins 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503620A SE505316C2 (sv) | 1995-10-17 | 1995-10-17 | Användning av proteinet S-100b för framställning av läkemedel för nervceller |
| PCT/SE1996/001305 WO1997014427A1 (fr) | 1995-10-17 | 1996-10-15 | UTILISATION DE LA PROTEINE S-100b DANS DES MEDICAMENTS, ET MEDICAMENTS CONTENANT LA PROTEINE S-100b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981719D0 NO981719D0 (no) | 1998-04-16 |
| NO981719L true NO981719L (no) | 1998-06-16 |
Family
ID=20399846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981719A NO981719L (no) | 1995-10-17 | 1998-04-16 | Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5990080A (fr) |
| EP (1) | EP0952844A1 (fr) |
| JP (1) | JPH11515003A (fr) |
| AU (1) | AU713332B2 (fr) |
| CA (1) | CA2235278A1 (fr) |
| CZ (1) | CZ116698A3 (fr) |
| EE (1) | EE9800108A (fr) |
| NO (1) | NO981719L (fr) |
| NZ (1) | NZ320721A (fr) |
| SE (1) | SE505316C2 (fr) |
| WO (1) | WO1997014427A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258776B1 (en) * | 1997-08-12 | 2001-07-10 | Novartis Ag | Calcium-regulated kinase |
| US20020072493A1 (en) | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
| US20030108528A1 (en) * | 1998-05-19 | 2003-06-12 | Michal Eisenbach-Schwartz | Activated t-cells, nervous system-specific antigens and their uses |
| CA2328612A1 (fr) * | 1998-05-19 | 1999-11-25 | Yeda Research And Development Co., Ltd. | Lymphocytes t actives, antigenes specifiques du systeme nerveux et leur utilisation |
| DE19915485A1 (de) | 1999-04-07 | 2000-10-19 | Hugo A Katus | Therapie der Herzinsuffizienz |
| KR20040081431A (ko) | 2001-12-06 | 2004-09-21 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 운동신경 질환의 치료용 백신 및 치료 방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992010200A1 (fr) * | 1990-12-14 | 1992-06-25 | New York University | Interactions fonctionnelles entre un glial s-100b et des neurones serotoninergiques du systeme nerveux central |
-
1995
- 1995-10-17 SE SE9503620A patent/SE505316C2/sv not_active IP Right Cessation
-
1996
- 1996-10-15 WO PCT/SE1996/001305 patent/WO1997014427A1/fr not_active Ceased
- 1996-10-15 EE EE9800108A patent/EE9800108A/xx unknown
- 1996-10-15 CZ CZ981166A patent/CZ116698A3/cs unknown
- 1996-10-15 US US09/051,589 patent/US5990080A/en not_active Expired - Fee Related
- 1996-10-15 JP JP9515742A patent/JPH11515003A/ja not_active Withdrawn
- 1996-10-15 EP EP96935706A patent/EP0952844A1/fr not_active Ceased
- 1996-10-15 NZ NZ320721A patent/NZ320721A/en unknown
- 1996-10-15 CA CA002235278A patent/CA2235278A1/fr not_active Abandoned
- 1996-10-15 AU AU73523/96A patent/AU713332B2/en not_active Ceased
-
1998
- 1998-04-16 NO NO981719A patent/NO981719L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ116698A3 (cs) | 1998-09-16 |
| AU7352396A (en) | 1997-05-07 |
| SE9503620D0 (sv) | 1995-10-17 |
| NZ320721A (en) | 2000-07-28 |
| EP0952844A1 (fr) | 1999-11-03 |
| EE9800108A (et) | 1998-10-15 |
| JPH11515003A (ja) | 1999-12-21 |
| WO1997014427A1 (fr) | 1997-04-24 |
| CA2235278A1 (fr) | 1997-04-24 |
| US5990080A (en) | 1999-11-23 |
| SE9503620L (sv) | 1997-04-18 |
| SE505316C2 (sv) | 1997-08-04 |
| NO981719D0 (no) | 1998-04-16 |
| AU713332B2 (en) | 1999-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2152483T3 (es) | Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b. | |
| DK0830377T4 (da) | Glucagon-lignende peptid-2 og terapeutisk anvendelse deraf | |
| DE69100282D1 (de) | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. | |
| PT703786E (pt) | Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida | |
| NO924697D0 (no) | Kirurgisk implantat og en fremgangsmaate for behandling avkirurgisk implantat | |
| MY153718A (en) | Formulation of human antibodies for treating tnf-(?) associated disorders | |
| DE69623981D1 (de) | Nichtpolymere verabreichungssysteme mit verzögerter freisetzung | |
| UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
| ATE207743T1 (de) | Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa | |
| DE69623390D1 (de) | Aktive implantierbare medizinische Vorrichtung, insbesondere Herzschrittmacher oder Defibrillator | |
| DK0855916T3 (da) | Farmaceutisk præparat indeholdende en Activin-stimulator | |
| NO981719L (no) | Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b | |
| DE60009146D1 (de) | Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| ATA113492A (de) | Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven | |
| ATA901396A (de) | Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten | |
| GB9505082D0 (en) | Medicament | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| SE9000207D0 (sv) | Laekemedel samt anvaendningen av detsamma | |
| ES2103811T3 (es) | Terapia antiviral. | |
| ATE147988T1 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| NO882313D0 (no) | Desinfeksjonsmiddel og anvendelse av dette for aa desinfisere hud og overflater paa gjenstander. | |
| SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives | |
| DE19775036I2 (de) | Arzneimittel zur Behandlung von Augenentzündung. | |
| SE9002274D0 (sv) | Novel 3,3'-dithiobis(propionic esters). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |